World Congress on Thyroid Cancer (WCTC) 2025

Booth 49

Location: Boston, Massachusetts | Westin Boston Seaport District
Date: July 9-12, 2025

At a glance

We are pleased to be attending the 2025 World Congress on Thyroid Cancer, taking place in Boston, MA on July 9-12th. An oral presentation detailing trends in Afirma GSC results between Israel and the United States will be presented on Friday, July 11th at 10:30AM EDT.

Visit us at Booth 49 during the conference for more details on what’s new with Afirma, including the latest updates on Afirma GRID, our research use only resource for analysis of molecular characteristics that can help inform future prognostication and the management of patients with thyroid nodules and thyroid cancer.

Featured Presentations & Posters
Title Session Date Time Presenter Location
Comparative Afirma Genomic Sequencing Classifier (GSC) Molecular Analysis of Indeterminate Thyroid Nodules Between Israel and the United States Oral Presentation Friday, July 11 10:30 AM ET

Keep exploring

Veracyte Diagnostics Platform

A novel diagnostics platform helping unlock deeper cancer insights.

Clinical Studies

Studies demonstrating the impact of our tests across cancer types.

Scientific Publications

Veracyte publications and references showcasing discoveries and advancements.

Press Releases

New data, partner announcements, and financial reports.